Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonnardel-Phu, E.
Right arrow Articles by Vicaut, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonnardel-Phu, E.
Right arrow Articles by Vicaut, E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 10 2052-2058, Copyright © 1999 by American Diabetes Association


ARTICLES

Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo

E Bonnardel-Phu, JL Wautier, AM Schmidt, C Avila and E Vicaut
Department of Biophysics, F. Widal Hospital, Paris, France.

Advanced glycation end products (AGEs) are nonenzymatic glycosylated adducts of proteins that accumulate in vascular tissue during diabetes and aging. The aim of this work was to study the role of AGEs and of the oxidative mechanisms in diabetes-induced changes in vascular permeability. Intravital videomicroscopy was used to study albumin microvascular leakage in cremaster muscle. The extravasation of a fluorescent macromolecular tracer (fluorescein isothiocyanate-albumin) was measured for 1 h and, after computer-aided image analysis, was expressed as variations of normalized gray levels (arbitrary units). Extravasation of the macromolecular tracer was much higher in diabetic rats than in control rats (slope of extravasation versus time increased by >100%, P < 10(-4)). This increase was significantly inhibited when we blocked AGEs binding to their endothelial receptor by intravenous bolus of soluble recombinant receptor to AGEs (rR-RAGE) (slope of extravasation versus time decreased by 19, 30, and 40%, for 0.5, 2.5, and 5.15 mg/kg rR-RAGE, respectively) or by a 6 mg/kg intravenous bolus of antibody against RAGE (slope decreased by 53%). Systemic injection of probucol (an antioxidant) also significantly inhibited the increase in the extravasation of the macromolecular tracer occurring in experimental diabetes (slope decreased by 51%, P < 10(-4)). These results strongly suggest that in experimental diabetes the interaction of circulating AGEs and endothelial RAGE mediates albumin micro-vascular leakage, possibly via AGE-RAGE-dependent enhanced oxidant stress.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
R. Scalia, Y. Gong, B. Berzins, L. J. Zhao, and K. Sharma
Hyperglycemia Is a Major Determinant of Albumin Permeability in Diabetic Microcirculation: The Role of {micro}-Calpain
Diabetes, July 1, 2007; 56(7): 1842 - 1849.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. S. Jensen, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and B. G. Nordestgaard
Increased Transvascular Lipoprotein Transport in Diabetes: Association with Albuminuria and Systolic Hypertension
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4441 - 4445.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Kankova, A. Stejskalova, M. Hertlova, and V. Znojil
Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus
Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1093 - 1102.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. J. Stalker, Y. Gong, and R. Scalia
The Calcium-Dependent Protease Calpain Causes Endothelial Dysfunction in Type 2 Diabetes
Diabetes, April 1, 2005; 54(4): 1132 - 1140.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-L. Wautier and A. M. Schmidt
Protein Glycation: A Firm Link to Endothelial Cell Dysfunction
Circ. Res., August 6, 2004; 95(3): 233 - 238.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al.
Activation of Tubular Epithelial Cells in Diabetic Nephropathy
Diabetes, December 1, 2002; 51(12): 3532 - 3544.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and J. S. Jensen
Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique
Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1168 - 1174.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. A. Kent, V. M. Soukup, and R. H. Fabian
Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse
Stroke, October 1, 2001; 32(10): 2318 - 2327.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.